• 1457 Citations
  • 19 h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Xiao-Wu Deng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Radiotherapy Medicine & Life Sciences
Intensity-Modulated Radiotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Semiconductors Medicine & Life Sciences
Neck Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Radiotherapy
Drug Therapy
Survival
Chemoradiotherapy
Disease-Free Survival
2 Citations (Scopus)

Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study

Zhao, C., Miao, J. J., Hua, Y. J., Wang, L., Han, F., Lu, L. X., Xiao, W. W., Wu, H. J., Zhu, M. Y., Huang, S. M., Lin, C. G., Deng, X-W. & Xie, C. H., Jul 15 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 4, p. 836-844 9 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Chemoradiotherapy
chemotherapy
toxicity
induction
2 Citations (Scopus)

Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Tian, Y. M., Liu, M. Z., Zeng, L., Bai, L., Lin, C. G., Huang, S. M., Deng, X-W., Chong-Zhao, Lu, T-X. & Han, F., May 1 2019, In : Head and Neck. 41, 5, p. 1246-1252 7 p.

Research output: Contribution to journalArticle

Intensity-Modulated Radiotherapy
Survival
Neoplasm Metastasis
Nasopharyngeal carcinoma
Chemoradiotherapy
2 Citations (Scopus)

Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy

Miao, J., Wang, L., Zhu, M., Xiao, W., Wu, H., Di, M., Huang, Y., Huang, S., Han, F., Deng, X-W., Guo, X. & Zhao, C., Feb 1 2019, In : Oral Oncology. 89, p. 40-47 8 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Radiotherapy
Drug Therapy
Survival
Nasopharyngeal carcinoma